Medicine: What are the right targets for psychopharmacology?

被引：207

作者：

Hyman, SE

Fenton, WS ^{[1
]}

机构：

[1] NIMH, Nihon Univ, US Dept HHS, Bethesda, MD 20896 USA

[2] Harvard Univ, Cambridge, MA 02138 USA

来源：

SCIENCE | 2003年 / 299卷 / 5605期

关键词：

D O I：

10.1126/science.1077141

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

引用

页码：350 / 351

页数：2

共 23 条

[1]

[Anonymous], MENT HLTH REP SURG G

[2] Are schizophrenic and bipolar disorders related? A review of family and molecular studies [J].

Berrettini, WH .

BIOLOGICAL PSYCHIATRY, 2000, 48 (06) :531-538

[3] Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates [J].

Bilder, RM ;

Goldman, RS ;

Robinson, D ;

Reiter, G ;

Bell, L ;

Bates, JA ;

Pappadopulos, E ;

Willson, DF ;

Alvir, JMJ ;

Woerner, MG ;

Geisler, S ;

Kane, JM ;

Lieberman, JA .

AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (04) :549-559

[4] Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation [J].

Castner, SA ;

Williams, GV ;

Goldman-Rakic, PS .

SCIENCE, 2000, 287 (5460) :2020-2022

[5] The human genome project and its impact on psychiatry [J].

Cowan, WM ;

Kopnisky, KL ;

Hyman, SE .

ANNUAL REVIEW OF NEUROSCIENCE, 2002, 25 :1-50

[6]

Freedman R, 2000, AM J MED GENET, V97, P58, DOI 10.1002/(SICI)1096-8628(200021)97:1<58::AID-AJMG8>3.0.CO

[7]

2-Y

[8] Pharmacologic strategies for augmenting cognitive performance in schizophrenia [J].

Friedman, JI ;

Temporini, H ;

Davis, KL .

BIOLOGICAL PSYCHIATRY, 1999, 45 (01) :1-16

[9] Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: A comparison with Alzheimer's disease and normal aging [J].

Friedman, JI ;

Harvey, PD ;

Coleman, T ;

Moriarty, PJ ;

Bowie, C ;

Parrella, M ;

White, L ;

Adler, D ;

Davis, KL .

AMERICAN JOURNAL OF PSYCHIATRY, 2001, 158 (09) :1441-1448

[10]

Gold JM, 1999, AM J PSYCHIAT, V156, P1944

← 1 2 3 →